QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Research Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Geller, R. Articles by Frydman, J. Search for Related Content PubMed PubMed Citation Articles by Geller, R. Articles by Frydman, J. Social Bookmarking                   What's this?

Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance

¹ Department of Biological Sciences, Stanford University, Stanford, California 94305, USA; ² Department of Microbiology and Immunology, University of California at San Francisco, San Francisco, California 94143, USA

The genome diversity of RNA viruses allows for rapid adaptation to a wide variety of adverse conditions. Accordingly, viruses can escape inhibition by most antiviral compounds targeting either viral or host factors. Here we exploited the capacity of RNA viruses for rapid adaptation to explore the evolutionary constraints of chaperone-mediated protein folding. We hypothesized that inhibiting a host molecular chaperone required for folding of a viral protein would force the virus to evolve an alternate folding strategy. We identified the chaperone Hsp90 as an essential factor for folding and maturation of picornavirus capsid proteins. Pharmacological inhibition of Hsp90 impaired the replication of poliovirus, rhinovirus, and coxsackievirus in cell culture. Strikingly, anti-Hsp90 treatment did not yield drug-resistant viruses, suggesting that the complexity of capsid folding precludes the emergence of alternate folding pathways. These results reveal tight evolutionary constraints on chaperone-mediated protein folding, which may be exploited for viral inhibition in vivo. Indeed, Hsp90 inhibitors drastically reduced poliovirus replication in infected animals without the emergence of drug-resistant escape mutants. We propose that targeting folding of viral proteins may provide a general antiviral strategy that is refractory to development of drug resistance.

[Keywords: Evolution; protein folding; Hsp90; drug resistance; antiviral; picornavirus]

Received October 23, 2006; revised version accepted November 29, 2006.

E-MAIL raul.andino{at}ucsf.edu; FAX (415) 514-4112.

⁴ E-MAIL jfrydman{at}stanford.edu; FAX (650) 724-4927.

Supplemental material is available at http://www.genesdev.org.

Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1505307

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. K. Wandinger, K. Richter, and J. Buchner The Hsp90 Chaperone Machinery J. Biol. Chem., July 4, 2008; 283(27): 18473 - 18477. [Full Text] [PDF]

				T. Okamoto, H. Omori, Y. Kaname, T. Abe, Y. Nishimura, T. Suzuki, T. Miyamura, T. Yoshimori, K. Moriishi, and Y. Matsuura A Single-Amino-Acid Mutation in Hepatitis C Virus NS5A Disrupting FKBP8 Interaction Impairs Viral Replication J. Virol., April 1, 2008; 82(7): 3480 - 3489. [Abstract] [Full Text] [PDF]

				S. Taguwa, T. Okamoto, T. Abe, Y. Mori, T. Suzuki, K. Moriishi, and Y. Matsuura Human Butyrate-Induced Transcript 1 Interacts with Hepatitis C Virus NS5A and Regulates Viral Replication J. Virol., March 15, 2008; 82(6): 2631 - 2641. [Abstract] [Full Text] [PDF]

				W. E. Balch, R. I. Morimoto, A. Dillin, and J. W. Kelly Adapting Proteostasis for Disease Intervention Science, February 15, 2008; 319(5865): 916 - 919. [Abstract] [Full Text] [PDF]